Stay updated on Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.

Latest updates to the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page
- Check6 days agoChange DetectedA site-wide banner announces that NIH is transitioning to use “Super Intelligence” instead of “Artificial Intelligence,” with updates and FAQs available.SummaryDifference1%

- Check13 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check20 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the full trial details for NCT03048448. This blocks access to the study information and related sections on ClinicalTrials.gov.SummaryDifference17%

- Check62 days agoChange DetectedThe revision label changed from v3.6.5 to v3.6.6, signaling a software release. No study details or page content are affected by this change.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, signaling a new release of the page content. This represents a small version update rather than a substantive change to the information shown.SummaryDifference0.1%

Stay in the know with updates to Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.